Adthera Bio
Pre-clinicalAdthera Bio is a digital-first CDMO focused exclusively on cell and gene therapy. We bring novel ATMP therapies to market through innovative process development, automation, and regulatory compliance.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $17.5M
About
Adthera Bio is a digital-first CDMO focused exclusively on cell and gene therapy. We bring novel ATMP therapies to market through innovative process development, automation, and regulatory compliance.
Drug DeliveryBiologics
Funding History
2Total raised:$17.5M
Series A$15MMar 15, 2023
Seed$2.5MJun 15, 2021